SarahATaylorMD

PubMed

• Oligoclonal immunoglobulin repertoire in biliary remnants of biliary atresia.
  Taylor, S. A.,Malladi, P.,Pan, X.,Wechsler, J. B.,Hulse, K. E.,Perlman, H.,Whitington, P. F.> ;Sci Rep. 2019 Mar 16
• 9 citations
  Correction: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma [J Transl Med., 16, (...
  Linda M. Liau, Keyoumars Ashkan, David Tran, Jian Campian, John E. Trusheim, Charles S. Cobbs, Jason Heth, Michael Salacz, Sarah A. Taylor, Stacy D. D’Andre, Fabio M. ...> ;Journal of Translational Medicine. 2018 Jun 29
• 167 citations
  First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
  Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim, Charles S Cobbs, Jason A Heth, Michael Salacz, Sarah Taylor, Stacy D D'Andre, Fabio M Iw...> ;Journal of Translational Medicine. 2018 May 29
• 8 citations
  Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer.
  Chao H. Huang, Stephen K. Williamson, Prakash Neupane, Sarah A. Taylor, Ace Allen, Nora J. Smart, Adelina M. Uypeckcuat, Sarah Spencer, Jo Wick, Holly J. Smith, Peter ...> ;Frontiers in Oncology. 2016 Jan 13
• 12 citations
  Improved sleep after Qigong exercise in breast cancer survivors: A pilot study
  Wen Liu, Lauren Schaffer, Natalie Herrs, Christine Chollet, Sarah A. Taylor> ;Asia-Pacific Journal of Oncology Nursing. 2015 Oct 1
• 71 citations
  An analysis of the distress thermometer problem list and distress in patients with cancer
  Lisa VanHoose, Lora L. Black, Kimberly G. Doty, Dory Sabata, Philip Twumasi-Ankrah, Sarah A. Taylor, Rhonda Johnson> ;Supportive Care in Cancer. 2015 May 1
• 27 citations
  Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer
  Heather Male, Vijay Patel, Mark A. Jacob, Emma Borrego-Diaz, Kun Wang, Derek A. Young, Amanda L. Wise, Chao Huang, Peter J. Van Veldhuizen, Amy O'Brien-Ladner, Stephen...> ;Lung Cancer. 2012 Aug 1
• 15 citations
  Overactivation of Ras signaling pathway in CD133+ MPNST cells
  Emma Borrego-Diaz, Kaoru Terai, Kristina Lialyte, Amanda L. Wise, Tuba Esfandyari, Fariba Behbod, Victor F. Mautner, Melanie Spyra, Sarah A. Taylor, Luis F. Parada, Me...> ;Journal of Neuro-Oncology. 2012 Apr 8
• 1 citations
  Docetaxel As Monotherapy in the Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients
  Ashok K. Malani, Rony M. Abou-Jawde, Jaswinder Singh, Sarah A. Taylor> ;Journal of Clinical Oncology. 2007 Mar 20
• 10 citations
  Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and per...
  Maurie Markman, Tracy Glass, Harriet O. Smith, Kenneth D. Hatch, Geoffrey R. Weiss, Sarah A. Taylor, J.Wendall Goodwin, David S. Alberts> ;Gynecologic Oncology. 2003 Mar 1
• 3 citations
  Phase II trial of amonafide in central nervous system tumors: a Southwest Oncology Group study.
  Sarah A. Taylor, Cathryn Rankin, Jeannette J. Townsend, Johnny B. Craig, Ralph B. Vance, Dilip L. Solank, Thomas D. Brown, Kurt A. Jaeckle> ;Investigational New Drugs. 2002 Feb 1
• 17 citations
  Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin–etoposide and daily thoracic radiotherapy in limited small-cell lung cancer
  Charles R. Thomas, Dorothy Giroux, Lalitha M Janaki, Andrew T. Turrisi, John Crowley, Sarah A. Taylor, J.Dean McCracken, P.G. Shankir Giri, William Gordon, Robert B. L...> ;Lung Cancer. 2001 Aug 1
• 23 citations
  Cisplatin, Etoposide, and Paclitaxel with Granulocyte Colony-Stimulating Factor in Untreated Patients with Extensive-Stage Small Cell Lung Cancer A Phase II Trial of t...
  Karen Kelly, Laura C. Lovato, Paul A. Bunn, Robert B. Livingston, Jeffrey Zangmeister, Sarah A. Taylor, Debasish F. Roychowdhury, John Crowley, David R. Gandara> ;Clinical Cancer Research. 2001 Aug 1
• 3 citations
  Phase II Trial of CI-980 in Patients with Disseminated Malignant Melanoma and no Prior Chemotherapy – A Southwest Oncology Group Study
  Robert P. Whitehead, Joseph M. Unger, Lawrence E. Flaherty, John R. Eckardt, Sarah A. Taylor, Mukund S. Didolkar, Wolfram E. Samlowski, Vernon K. Sondak> ;Investigational New Drugs. 2001 Jan 1
• 1 citations
  'Neo-FAC' (5-fluorouracil, doxorubicin, and cyclophosphamide) for poor-prognosis stage IV breast cancer: a Southwest Oncology Group Phase II Study.
  Georgiana K. Ellis, Stephanie Green, Robert B. Livingston, Michael J. Kraut, H. Irving Pierce, Jorge C. Paradelo, Sarah A. Taylor, Silvana Martino> ;American Journal of Clinical Oncology. 1999 Oct 1
• 12 citations
  A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study.
  Vernon K. Sondak, P. Y. Liu, Lawrence E. Flaherty, William S. Fletcher, Phillip Periman, David R. Gandara, Sarah A. Taylor, Stanley P. Balcerzak, Frank L. Meyskens> ;The Cancer Journal from Scientific American. 1999 Jan 1
• 9 citations
  Phase II study of Didemnin B in central nervous system tumors: a Southwest Oncology Group study
  Sarah A. Taylor, Dorothy Giroux, Kurt A. Jaeckle, Timothy J. Panella, Shaker R. Dakhil, S. Clifford Schold> ;Investigational New Drugs. 1998 Dec 1
• 47 citations
  Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: a Southwest Oncology Group Study.
  Sydney E. Salmon, John Crowley, Stanley P. Balcerzak, Ralph W. Roach, Sarah A. Taylor, Saul E. Rivkin, Wolfram E. Samlowski> ;Journal of Clinical Oncology. 1998 Mar 1
• 60 citations
  Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinoma: a Southwest Oncology Group study.
  R P Whitehead, Joth Jacobson, Thomas D. Brown, Sarah A. Taylor, Geoffrey R. Weiss> ;Journal of Clinical Oncology. 1997 Jun 1
• 30 citations
  Chylothorax: a complication of a left subclavian vein thrombosis.
  P J Van Veldhuizen, Sarah A. Taylor> ;American Journal of Clinical Oncology. 1996 Apr 1
• 15 citations
  Evaluation of topotecan in patients with recurrent for metastatic squamous cell carcinoma of the head and neck : A phase II Southwest Oncology Group study
  Roy E. Smith, Danika Lew, G. I. Rodriguez, Sarah A. Taylor, David E. Schuller, John F. Ensley> ;Investigational New Drugs. 1996 Jan 1
• 666 citations
  Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncolo...
  Kathy S. Albain, Valerie W. Rusch, John Crowley, Thomas W. Rice, Andrew T. Turrisi, James K. Weick, Vassyl A. Lonchyna, Cary A. Presant, Robert McKenna, David R. Ganda...> ;Journal of Clinical Oncology. 1995 Aug 1
• 1 citations
  A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma
  Micheal R. Grever, Jacqueline Benedetti, Stanley P. Balcerzak, Sarah A. Taylor, Thomas P. Miller, Shaker R. Dakhil> ;Investigational New Drugs. 1994 Jan 1
• 4 citations
  New agents in the treatment of primary brain tumors.
  Sarah A. Taylor> ;Journal of Neuro-Oncology. 1994 Jan 1
• 13 citations
  Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group study.
  M. Ernest Marshall, Michael K. Wolf, E. David Crawford, Sarah A. Taylor, Brent A. Blumenstein, Robert C. Flanigan, Frederick J. Meyers, Harry E. Hynes, Bart Barlogie, ...> ;Investigational New Drugs. 1993 May 1
• Join now to see all